This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Adenocarcinoma
|
Academic Article
|
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer.
|
Academic Article
|
Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma.
|
Academic Article
|
A phase II trial of perifosine in locally advanced, unresectable, or metastatic pancreatic adenocarcinoma.
|
Academic Article
|
Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
|
Academic Article
|
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.
|
Academic Article
|
Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question.
|
Academic Article
|
Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
|
Academic Article
|
Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.
|
Academic Article
|
Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report.
|
Academic Article
|
A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.
|
Academic Article
|
5-fluorouracil-induced coronary vasospasm.
|
Academic Article
|
Phase 1 experience with an anti-glycotope monoclonal antibody, RAV12, in recurrent adenocarcinoma.
|
Academic Article
|
Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma.
|
Academic Article
|
Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
|
Academic Article
|
Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer.
|